DavosPharma Revenue and Competitors

Upper Saddle River, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • DavosPharma's estimated annual revenue is currently $6.2M per year.(i)
  • DavosPharma's estimated revenue per employee is $201,000

Employee Data

  • DavosPharma has 31 Employees.(i)
  • DavosPharma grew their employee count by 0% last year.

DavosPharma's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
VP Global API DevelopmentReveal Email/Phone
3
VP ChemistryReveal Email/Phone
4
VP API and Formulation DevelopmentReveal Email/Phone
5
Head BiologyReveal Email/Phone
6
Sr. Director, MarketingReveal Email/Phone
7
EVP & Chief Financial OfficerReveal Email/Phone
8
Director Business DevelopmentReveal Email/Phone
9
Director, Global Supply Chain and Business DevelopmentReveal Email/Phone
10
Senior Director CMC – Drug Product FormulationReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is DavosPharma?

DavosPharma is a leading provider of discovery, chemistry, and formulation services. We provide scientific expertise and technical and regulatory support during drug development for academic institutions, emerging biotech, and established multinationals. In an increasingly fragmented marketplace, DavosPharma strives to deliver the best solutions for your specific needs, timelines and budgets. We are unique in the industry because we are paid on deliverables, not ‘best effort’. DavosPharma has a 40 year track record of continuous success. Benefit from our experience and talent.

keywords:N/A

N/A

Total Funding

31

Number of Employees

$6.2M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A3210%N/A
#2
$7.2M413%N/A
#3
$7.5M504%N/A
#4
$1.7M548%N/A
#5
N/A627%N/A